CAND PHARM C. CRISTOFFERSEN AS
Organization
- Chairman of the board
- Years since formation
- 19 years
- since Jan 12, 2006
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 5,000
- 2 share classes
- Total number of shareholders
- 3
- persons
- Belongs to group of
Financials
- Annual total result 2024
- 9,613,452
- NOK
- Total equity 2024
- 29,678,557
- NOK
Last update: Sep 9, 2025
Management
Board
| Name | Role | Shares |
|---|---|---|
MC | Board Member | - |
| Chairman | 99.98 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
| Chairman | 99.98 % directly |
Last update: Aug 27, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Class B shares | 4,900 | 98 % | |
| A-shares | 99 | 1.98 % | |
MC | A-shares | 1 | 0.02 % |
Shares owned by the CAND PHARM C. CRISTOFFERSEN AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 400 | 100 % | |
| NO0004826801 | 2,200 | 0.07 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -40,235Employees: 0
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | 9,613,452 | 8,333,346 | 8,637,418 | 23,427,439 |
Total assets | 36,838,003 | 33,159,207 | 30,759,100 | 26,097,667 |
Total liabilities | 7,159,446 | 6,094,102 | 6,027,342 | 4,003,326 |
Total equity | 29,678,557 | 27,065,105 | 24,731,759 | 22,094,341 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 40,235 | 41,215 | 37,487 | 29,739 |
Operating result | -40,235 | -41,215 | -37,487 | -29,739 |
Financial income/costs | 9,813,133 | 8,468,663 | 8,702,247 | 23,460,504 |
Profit before tax | 9,772,898 | 8,427,448 | 8,664,760 | 23,430,765 |
Total tax & extraordinary income/cost | 159,446 | 94,102 | 27,342 | 3,326 |
Annual Total Result | 9,613,452 | 8,333,346 | 8,637,418 | 23,427,439 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 6,150,780 | 6,650,780 | 2,650,780 | 2,650,780 |
Total current assets | 30,687,223 | 26,508,427 | 28,108,320 | 23,446,887 |
Total assets | 36,838,003 | 33,159,207 | 30,759,100 | 26,097,667 |
Short term debt | 7,159,446 | 6,094,102 | 6,027,342 | 4,003,326 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 7,159,446 | 6,094,102 | 6,027,342 | 4,003,326 |
Contributed capital | 2,645,622 | 2,645,622 | 2,645,622 | 2,645,622 |
Retained earnings | 27,032,935 | 24,419,483 | 22,086,137 | 19,448,719 |
Total equity | 29,678,557 | 27,065,105 | 24,731,759 | 22,094,341 |
Total equity and liabilities | 36,838,003 | 33,159,207 | 30,759,101 | 26,097,667 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises